<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>NEUROSENSE THERAPEUTICS RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Fri, 26 Jun 2026 00:56:02 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/neurosense%5Ftherapeutics%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>NEUROSENSE THERAPEUTICS RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>World-Renowned Alzheimer's Expert Prof. Steven Arnold Joins NeuroSense SAB</title><pubDate>Thu, 08 Jan 2026 14:45:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/world-renowned-alzheimer-s-expert-prof-steven-arnold-joins-neurosense-sab-15402156</link><description><![CDATA[<p><p class="prntac" xmlns="http://www.w3.org/1999/xhtml"><b><i>Alzheimer's Clinical and Biomarker Outcomes Expected in Q1 2026</i></b><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">CAMBRIDGE, Mass., <span  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/world-renowned-alzheimer-s-expert-prof-steven-arnold-joins-neurosense-sab-15402156</guid></item></channel></rss>
